These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 14707991)

  • 1. Lipids, diabetic maculopathy, and cardiovascular risk.
    Gandhi JS
    Eye (Lond); 2004 Jan; 18(1):108-9. PubMed ID: 14707991
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of serum lipids in exudative diabetic maculopathy: is there a place for lipid lowering therapy?
    Chowdhury TA; Hopkins D; Dodson PM; Vafidis GC
    Eye (Lond); 2002 Nov; 16(6):689-93. PubMed ID: 12439660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic maculopathy and lipid-lowering therapy.
    Misra A; Vikram NK; Kumar A
    Eye (Lond); 2004 Jan; 18(1):107-8. PubMed ID: 14707990
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lipid balance and diabetic retinopathy. (Critical analysis of 50 cases)].
    Bonnet M; Pingault C; Bakri M; Sibille
    Bull Soc Ophtalmol Fr; 1972 Nov; 72(11):1035-44. PubMed ID: 4667824
    [No Abstract]   [Full Text] [Related]  

  • 5. [Eye changes in hyperlipoproteinemia].
    Dvorák V; Vaverková H; Kubasta M; Mikulíková I
    Cesk Oftalmol; 1971 May; 27(3):149-52. PubMed ID: 5089267
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease.
    Staels B; Maes M; Zambon A
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):542-53. PubMed ID: 18628776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing drug usage and adverse effects. Part III: Cardiovascular disease and hyperlipidemia.
    Baron M
    Health Care Food Nutr Focus; 2005 Jun; 22(6):7-11. PubMed ID: 15923907
    [No Abstract]   [Full Text] [Related]  

  • 8. [Various internal medicine aspects of the future therapy for diabetic retinopathy].
    Houtsmuller AJ
    Klin Monbl Augenheilkd; 1972 May; 160(5):521-7. PubMed ID: 5075948
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipid management in Type 1 diabetes.
    Pachaiappan KJ; Patel V; Morrissey J; Gadsby R
    Diabet Med; 2006 Mar; 23 Suppl 1():11-4. PubMed ID: 16483259
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipids in type 2 diabetes.
    Laakso M
    Semin Vasc Med; 2002 Feb; 2(1):59-66. PubMed ID: 16222596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lipids--diagnosis and therapy in type 2 diabetes].
    Wascher TC
    Acta Med Austriaca; 2004; 31(5):168-9. PubMed ID: 15747990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and risk factors for diabetic retinopathy--a study of 217 patients from University of Malaya Medical Centre.
    Tajunisah I; Nabilah H; Reddy SC
    Med J Malaysia; 2006 Oct; 61(4):451-6. PubMed ID: 17243523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Moon YS; Kashyap ML
    Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for diabetic retinopathy in Kuwaiti type 2 diabetic patients.
    Al-Adsani AM
    Saudi Med J; 2007 Apr; 28(4):579-83. PubMed ID: 17457481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing diabetic complications: a primary care perspective.
    Zimmet P
    Diabetes Res Clin Pract; 2009 May; 84(2):107-16. PubMed ID: 19278746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease.
    Robson J
    Heart; 2008 Oct; 94(10):1331-2. PubMed ID: 18701534
    [No Abstract]   [Full Text] [Related]  

  • 17. Epidemiology of diabetic retinopathy.
    Chew EY
    Hosp Med; 2003 Jul; 64(7):396-9. PubMed ID: 12886848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor.
    O'Keefe JH; Bell DS
    Am J Cardiol; 2007 Sep; 100(5):899-904. PubMed ID: 17719342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving lipid goal attainment: is it enough?
    Gotto AM
    Circulation; 2009 Jul; 120(1):3-5. PubMed ID: 19546383
    [No Abstract]   [Full Text] [Related]  

  • 20. [Myocardial infarction in a 26-year-old patient with diabetes type 1].
    Rogowicz A; Zozulińska D; Wierusz-Wysocka B
    Kardiol Pol; 2007 Nov; 65(11):1363-6; discussion 1366-7. PubMed ID: 18058587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.